Preliminary study to explore the effects of mirtazapine on appetite in advanced cancer patients.

Trial Profile

Preliminary study to explore the effects of mirtazapine on appetite in advanced cancer patients.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Mirtazapine (Primary)
  • Indications Anorexia
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jun 2017 Planned End Date changed from 1 May 2017 to 1 Jan 2019.
    • 16 Jun 2017 Planned primary completion date changed from 1 May 2017 to 1 Jan 2019.
    • 22 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top